Healthcare

Karyopharm Therapeutics shares tumbled on Monday, Oct. 5, as the Nasdaq Composite hit a record, but no company news was found to account for the slide.

Novavax shares surged on Monday, Oct. 5, as reports of a suspected plague case at a Russian research institute, which has not been confirmed, sent traders intoVaccineand biodefense stocks.

PacBio shares surged on Monday, Oct. 5, after EpiSign and Geneyx Genomex announced a rare-disease partnership built on data from PacBio's HiFi sequencing technology.

Vaxcyte shares soared on Monday, Oct. 5, after its VAX-31 pneumococcal vaccine met all of its main goals in a pivotal trial, and Guggenheim called the result "a major win."

Zentalis Pharmaceuticals shares rose on Monday after Leerink Partners upgraded the cancer-drug developer to Outperform and doubled its price target ahead of key data later this month.

Aclaris Therapeutics (NASDAQ:ACRS) is advancing a diversified pipeline of immuno-inflammatory product candidates, including bosakitug, an anti-TSLP monoclonal antibody in Phase 2 development for conditions such as atopic dermatitis and asthma, zunsemetinib, a dual ITK and JAK3 inhibitor with Phase 2a data presented at a …

Aethlon Medical's (NASDAQ:AEMD) July 2026 follow-on offering, which raised 4 million dollars in gross proceeds through units priced at roughly 71 cents each, included a 90-day lock-up restricting directors and officers from selling their holdings. That lock-up period's scheduled end date falls in early …